Insulet raises revenue expectations for 2026

Insulet raises revenue expectations for 2026 is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Elise Reuter · 2026-05-06

CEO Ashley McEvoy also shared an update on the company’s recent recall of insulin patch pumps.

Source: MedTech Dive